DARATUMUMAB
daratumumab 1.8 g/15 mL injection, 15 mL vial
DARATUMUMAB (15088D)
15088D
Manner of administration:Injection
Restriction
Indication: Untreated multiple myeloma
Treatment phase: Initial treatment as first-line drug therapy from week 0 to week 24
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 15 | DPMQ: $6,822.70 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Darzalex SC | |||||